
Drug-development, dose-selection, rational combinations from bench-to-bedside: are there any lessons worth revisiting?
Author(s) -
Alexander J. Bridges,
Ranjit K. Mehta,
Sushmita Shukla,
Matthew J. Schipper,
Theodore S. Lawrence,
Mukesh K. Nyati
Publication year - 2021
Publication title -
oncotarget
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 1.373
H-Index - 127
ISSN - 1949-2553
DOI - 10.18632/oncotarget.27931
Subject(s) - medicine , clinical trial , intensive care medicine , drug development , harm , drug , risk analysis (engineering) , rule of thumb , bench to bedside , clinical study design , pharmacology , medical physics , computer science , psychology , social psychology , algorithm